Novo Nordisk A/S

Novo Nordisk affirms a public commitment to align its external engagement with climate goals, noting that "we have set ambitious emission reduction targets with an emissions trajectory in line with the 1.5 degree pathway in the Paris Agreement," and explicitly answering "Yes" when asked if it has a position to conduct engagement in line with the Paris Agreement. However, the company does not disclose any processes for how these external engagement or lobbying activities are monitored or managed for alignment with its climate commitments, nor does it identify any individual or committee responsible for overseeing this alignment. We found no evidence of a defined governance structure, review procedures, or accountability measures specific to lobbying or policy advocacy alignment.